Prospective, randomized, double-blind, placebo-controlled, multicenter study to investigate the efficacy and safety of NT 201 in the treatment of lower limb spasticity caused by stroke or traumatic brain injury in adult subjects, followed by an open label extension with or without combined upper limb treatment
After a stroke or head injury, some people develop painful muscle stiffness in their legs, known as spasticity. This stiffness can make walking, balance, and daily activities difficult. This study is testing an injection called Xeomin to see if it safely relaxes tight leg muscles. Participants are randomly chosen to receive either Xeomin or a dummy injection (placebo) into their leg muscles. Doctors will check muscle stiffness and ankle movement four to six weeks later. After this first phase, there is an extension period where all volunteers can receive the real medicine. This stage can also treat stiff arm muscles if needed. The main goal is to find out if Xeomin helps people achieve their personal movement goals and improves their everyday quality of life.
Em resumo
Sobre o que é este estudo?
A stroke or traumatic brain injury can disrupt normal signals between the brain and muscles. This often leads to a condition called spasticity, where muscles stay tight and contracted. In the legs, this stiffness can point the foot downwards or make the knee hard to bend. Over time, this causes discomfort, walking problems, and a higher risk of trips and falls.
This clinical trial is testing a medicine called Xeomin (a purified botulinum toxin). When injected into stiff muscles, it works by temporarily calming the overactive nerve signals, allowing the muscle to relax. While similar treatments exist, researchers want to confirm how well this specific medicine works for lower limb stiffness caused by brain injury or stroke.
In the first part of the trial, participants are divided into two groups: one receives Xeomin and the other receives an inactive dummy injection (placebo). Neither you nor your doctor will know which one you receive at first. Later, in an extension phase, every participant has the chance to receive the real medicine, which may also be used to treat stiff arm muscles if appropriate.
Pontos principais
- Tests Xeomin injections to treat leg and ankle stiffness after a stroke or head injury.
- Compares the active medicine against a dummy injection (placebo) in the first phase.
- Includes an extension phase where all participants can receive the real medicine.
- Aims to improve ankle mobility, ease walking, and help people reach daily goals.
- Open to adults aged 18 and older who meet the health criteria.
Quem pode ser elegível?
This study is open to adults aged 18 and over who have muscle stiffness in their legs caused by a stroke or a traumatic brain injury. Both men and women can take part.
To be eligible, the muscle tightness must be affecting your lower leg, such as your ankle movement. You must also be able to visit the study clinic for regular check-ups, assessments, and injections.
You may not be eligible if you have recently received certain other muscle treatments, if you have other nerve disorders, or if you have medical conditions that make injections unsafe. A study doctor will review your full medical history before you join to make sure the trial is safe for you.
Este estudo pode ser adequado para você?
Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.
- You are aged 18 or older.
- You have had a stroke or a traumatic brain injury.
- You experience muscle tightness or stiffness in your leg or ankle.
- You are able to attend regular clinic appointments for checks and injections.
- You are willing to track your mobility goals with the study doctors.
O que envolve a participação?
Taking part involves several visits to a hospital clinic over a number of months. At your first visit, doctors will assess your general health, examine your leg stiffness, and help you set personal movement goals. During treatment visits, a trained doctor will inject the study medicine directly into specific leg muscles using a very fine needle.
You will return for follow-up appointments, especially around weeks 4 and 6, so the team can measure your ankle flexibility, check your progress, and hear feedback from you and your caregiver. After this initial stage, you may join an extension study where everyone receives the active treatment. The team will closely check your safety and well-being at every step.
Riscos e benefícios potenciais
Localizações (9)
- —Não verificadoFrança
- —Não verificadoEslováquia
- —Não verificadoItália
- —Não verificadoEspanha
- —Não verificadoPolônia
- —Não verificadoAlemanha
- —Não verificadoHungria
- —Não verificadoBélgica
- —Não verificadoChéquia
Perguntas frequentes
What is lower limb spasticity?
It is an involuntary tightness or stiffness in the leg muscles that often happens after brain damage, such as a stroke or head injury, making walking and bending joints difficult.
O que é um placebo?
A placebo is a harmless dummy treatment that looks identical to the real medicine but contains no active drug. It helps researchers prove if the medicine truly works.
Will the injections hurt?
Most people feel a brief pinch or mild ache when the needle enters the muscle, similar to having a routine vaccine or blood test.
Will I definitely get the real medicine?
In the first stage, you have an equal chance of receiving either the real medicine or the placebo. In the second stage (the extension), all participants receive the real medicine.
Do I have to pay to take part?
No. The study treatment, tests, and medical visits are free, and trials often help cover your travel expenses.
Como saber mais
Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.
Interessado em participar?
Discussão
Discussão da comunidade
Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.